Venetoclax for Myeloma: Trial on Hold, Now Details of Benefit Venetoclax for Myeloma: Trial on Hold, Now Details of Benefit

Although the BELLINI trial was put on partial hold, the trial was allowed to continue for patients for whom the addition of venetoclax showed benefit. New data now identify this subgroup.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news